Title:
AQUEOUS LIQUID FORMULATION
Document Type and Number:
WIPO Patent Application WO/2020/071297
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a formulation technique pertaining to an aqueous liquid formulation that contains a water-soluble polymer, and brimonidine and/or a salt thereof. An aqueous liquid formulation containing a water-soluble polymer, brimonidine and/or a salt thereof, and polyhexanide and/or a salt thereof can suppress decreases in viscosity over time, can also suppress decreases in the content of brimonidine and/or salt thereof over time, and can provide exceptional formulation stability.
Inventors:
IEMOTO SUZUKA (JP)
Application Number:
PCT/JP2019/038443
Publication Date:
April 09, 2020
Filing Date:
September 30, 2019
Export Citation:
Assignee:
SENJU PHARMA CO (JP)
International Classes:
A61K31/498; A61K9/08; A61K47/30; A61K47/32; A61K47/34; A61K47/36; A61P27/06
Domestic Patent References:
| WO2017099207A1 | 2017-06-15 | |||
| WO2015137328A1 | 2015-09-17 |
Foreign References:
| JP2012246304A | 2012-12-13 |
Other References:
MIZUNO, SHIGEO: "Glaucoma and ocular hypertension treatment agent [AIPHAGAN (trade mark) Ophthalmic Solution 0.1%", JAPANESE JOURNAL OF OCULAR PHARMACOLOGY, vol. 27, 2013, pages 13 - 17, ISSN: 0914-1405
Attorney, Agent or Firm:
TANAKA, Junya et al. (JP)
Download PDF: